ExploreWatchlistsPricing
  1. JP-listed companies
  2. ZERIA PHARMCEUTICAL CO., LTD.
  3. Financials
  4. Operating income

ZERIA PHARMCEUTICAL CO., LTD. (4559)

Market cap
¥124.2B
P/E ratio
10.3x
Japanese pharmaceutical company that develops and sells prescription drugs, over-the-counter medications, and health products through multiple subsidiaries worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Mar 31, 202612,374+1.45%
Mar 31, 202512,198+26.77%
Mar 31, 20249,622+6.73%
Mar 31, 20239,015+41.61%
Mar 31, 20226,366+84.95%
Mar 31, 20213,442-15.94%
Mar 31, 20204,095+9.57%
Mar 31, 20193,737-22.63%
Mar 31, 20184,830+6.36%
Mar 31, 20174,542-0.53%
Mar 31, 20164,566+70.45%
Mar 31, 20152,679

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat